BackBioCardia - Warrants (26/07/2022) Overview

BioCardia - Warrants (26/07/2022) Receivables

BioCardia - Warrants (26/07/2022)'s receivables is $30K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$30000.00
200.00% YoYΔ $20000.00 vs prior year quarter

Peer trimmed avg / median

Loading

BioCardia - Warrants (26/07/2022) Receivables History

Loading

BioCardia - Warrants (26/07/2022) vs. peers: Receivables Comparison

Loading

BioCardia - Warrants (26/07/2022) Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

BioCardia - Warrants (26/07/2022) (BCDAW) FAQ

As of the most recent data (June 2026), BCDAW shows a receivables of $30K. That compares with $10K in the prior-year period — up 200.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BCDAW's receivables is now $30K (was $10K) — a 200.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether BioCardia - Warrants (26/07/2022) is outperforming or lagging.

Tracking BCDAW's receivables over time shows whether BioCardia - Warrants (26/07/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $30K That compares with $10K in the prior-year period — up 200.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has BioCardia - Warrants (26/07/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $30K) with ownership activity and broader fundamentals.

BioCardia - Warrants (26/07/2022)'s receivables is $30K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.